Prediction of prostate cancer recurrence using quantitative phase imaging

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Sridharan, Shamira ^a   Macias, Virgilia ^b   Tangella, Krishnarao ^c   Kajdacsy Balla, André ^b   Popescu, Gabriel ^a  

^a United States of America   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANISOTROPY; BLOOD; CANCER GRADING; CASE CONTROL STUDY; DISEASE FREE SURVIVAL; HUMAN; INTERFERENCE MICROSCOPY; MALE; METASTASIS; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR RECURRENCE;

ANISOTROPY; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; HUMANS; MALE; MICROSCOPY, INTERFERENCE; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84929353050     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09976     Document Type: Article

References (36)

1. Howlader N., et al. SEER Cancer Statistics Review, 1975-2011. (National Cancer Institute, Bethesda, MD, 2014).
2. Wilt, T. J., et al. Radical Prostatectomy versus Observation for Localized Prostate Cancer. New Engl. J. Med. 367, 203-213 (2012).
3. Eggener, S. E., et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J. Urol. 185, 869-875 (2011).
4. Stephenson, A. J., et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J. Clin. Oncol. 27, 4300-4305 (2009).
5. Hull, G.W., et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J. Urol. 167, 528-534 (2002).
6. Stephenson, A. J., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J. Clin. Oncol. 23, 7005-7012 (2005).
7. Cooperberg, M. R., Hilton, J. F. & Carroll, P. R. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 117, 5039-5046 (2011).
8. Sergeev, A., et al. In vivo endoscopic OCT imaging of precancerand cancer states of human mucosa. Opt. Exp. 1, 432-440 (1997).
9. Bouma, B. E., Tearney, G. J., Compton, C. C. & Nishioka, N. S. High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography. Gastrointest. Endosc. 51, 467-474 (2000).
10. Sivak, Jr, M. V., et al. High-resolution endoscopic imaging of the GI tract using optical coherence tomography. Gastroint. Endosc. 51, 474-479 (2000).
11. Escobar, P. F., et al. Diagnostic efficacy of optical coherence tomography in the management of preinvasive and invasive cancer of uterine cervix and vulva. Int. J. Gynecol. Cancer 14, 470-474 (2004).
12. Pan, Y. T., et al. Enhancing early bladder cancer detection with fluorescence-guided endoscopic optical coherent tomography. Opt. Lett. 28, 2485-2487 (2003).
13. Mogensen, M., et al. OCT imaging of skin cancer and other dermatological diseases. J. Biophotonics 2, 442-451 (2009).
14. Nguyen, F. T., et al. Intraoperative evaluation of breast tumor margins with optical coherence tomography. Cancer Res. 69, 8790-8796 (2009).
15. Radosevich, A. J., et al. Ultrastructural alterations in field carcinogenesis measured by enhanced backscattering spectroscopy. J. Biomed. Optics 18, 097002 (2013).
16. Subramanian, H., et al. Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. Opt. Lett. 34, 518-520 (2009).
17. Chung, L. K. Fibroblasts are critical determinants in prostatic cancer growth and dissemination. Cancer Metast. Rev. 10, 263-274 (1991).
18. Ambekar, R., et al. Quantifying collagen structure in breast biopsies using second-harmonic generation imaging. Biomed. Opt. Express 3, 2021-2035 (2012).
19. Nadiarnykh, O., LaComb, R. B., Brewer, M. A. & Campagnola, P. J. Alterations of the extracellular matrix in ovarian cancer studied by second harmonic generation imaging microscopy. BMC Cancer 10, 94 (2010).
20. Conklin, M. W., et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am. J. Path. 178, 1221-1232 (2011).
21. Wang, Z., Tangella, K., Balla, A. & Popescu, G. Tissue refractive index as marker of disease. J. Biomed. Opt. 16, 116017 (2011).
22. Kim, T., et al. White-light diffraction tomography of unlabeled live cells. Nat. Photon. 8, 256-263 (2014).
23. Popescu, G. Quantitative phase imaging of cells and tissues, (McGraw-Hill, New York, 2011).
24. Sutkowski, D. M., et al. Growth regulation of prostatic stromal cells by prostate-specific antigen. J. Natl. Cancer Inst. 91, 1663-1669 (1999).
25. Williams, S. A., Singh, P., Isaacs, J. T. & Denmeade, S. R. Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer? The Prostate 67, 312-329 (2007).
26. Rowley, D. What Might A Stromal Response Mean to Prostate Cancer Progression? Cancer Metast. Rev. 17, 411-419 (1998).
27. Tuxhorn, J. A., Ayala, G. E. & Rowley, D. R. Reactive Stroma in Prostate Cancer Progression. J. Urol. 166, 2472-2483 (2001).
28. Ayala, G., et al. Reactive Stroma as a Predictor of Biochemical-Free Recurrence in Prostate Cancer. Clin. Cancer Res. 9, 4792-4801 (2003).
29. Tuxhorn, J. A., et al. Reactive Stroma in Human Prostate Cancer: Induction of Myofibroblast Phenotype and Extracellular Matrix Remodeling. Clin. Cancer Res. 8, 2912-2923 (2002).
30. Jung, K., et al. Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: analytical aspects. The Prostate 34, 130-136 (1998).
31. Wood, M., et al. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin. Exp. Metastasis 15, 246-258 (1997).
32. Berman, J. J., et al. The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource. BMC Bioinformatics 5, 19 (2004).
33. Kajdacsy-Balla, A., et al. Practical aspects of Planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experience. J. Mol. Histol. 38, 113-121 (2007).
34. Liao, Z. & Datta, M. W. A simple computer program for calculating PSA recurrence in prostate cancer patients. BMC Urol. 4, 8 (2004).
35. Ding, H., et al. Measuring the scattering parameters of tissues from quantitative phase imaging of thin slices. Opt. Lett. 36, 2281 (2011).
36. Henyey, L. G. & Greenstein, J. L. Diffuse radiation in the Galaxy. Astrophys. J. 93, 70-83 (1941).